🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Taysha Gene Therapies, Inc. (TSHA)
NASDAQ: TSHA · Real-Time Price · USD
3.720
-0.050 (-1.33%)
At close: Nov 20, 2026, 4:00 PM EST
3.710
-0.010 (-0.27%)
After-hours: Nov 20, 2026, 7:56 PM EST

Taysha Gene Therapies Statistics

Total Valuation

TSHA has a market cap or net worth of $1.21 billion. The enterprise value is $844.65 million.

Market Cap1.21B
Enterprise Value 844.65M

Important Dates

The last earnings date was Thursday, November 12, 2026, before market open.

Earnings Date Nov 12, 2026
Ex-Dividend Date n/a

Share Statistics

TSHA has 326.05 million shares outstanding. The number of shares has increased by 26.02% in one year.

Current Share Class 326.05M
Shares Outstanding 326.05M
Shares Change (YoY) +26.02%
Shares Change (QoQ) +10.04%
Owned by Insiders (%) 8.07%
Owned by Institutions (%) 77.25%
Float 227.32M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 221.13
Forward PS 546.58
PB Ratio 3.40
P/TBV Ratio 3.40
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 153.99
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 18.56, with a Debt / Equity ratio of 0.15.

Current Ratio 18.56
Quick Ratio 18.42
Debt / Equity 0.15
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage -5,304.52

Financial Efficiency

Return on equity (ROE) is -54.18% and return on invested capital (ROIC) is -29.38%.

Return on Equity (ROE) -54.18%
Return on Assets (ROA) -27.35%
Return on Invested Capital (ROIC) -29.38%
Return on Capital Employed (ROCE) -39.90%
Weighted Average Cost of Capital (WACC) 10.98%
Revenue Per Employee $55,404
Profits Per Employee -$1.58M
Employee Count99
Asset Turnover 0.01
Inventory Turnover n/a

Taxes

Income Tax n/a
Effective Tax Rate n/a

Stock Price Statistics

The stock price has decreased by -7.23% in the last 52 weeks. The beta is 1.31, so TSHA's price volatility has been higher than the market average.

Beta (5Y) 1.31
52-Week Price Change -7.23%
50-Day Moving Average 4.35
200-Day Moving Average 5.28
Relative Strength Index (RSI) 34.73
Average Volume (20 Days) 2,873,098

Short Selling Information

The latest short interest is 53.48 million, so 16.40% of the outstanding shares have been sold short.

Short Interest 53.48M
Short Previous Month 51.25M
Short % of Shares Out 16.40%
Short % of Float 23.53%
Short Ratio (days to cover) 13.16

Income Statement

In the last 12 months, TSHA had revenue of $5.49 million and -$156.03 million in losses. Loss per share was -$0.42.

Revenue5.49M
Gross Profit 5.49M
Operating Income -164.44M
Pretax Income -156.03M
Net Income -156.03M
EBITDA -163.30M
EBIT -164.44M
Loss Per Share -$0.42
Full Income Statement

Balance Sheet

The company has $422.83 million in cash and $54.59 million in debt, with a net cash position of $368.24 million or $1.13 per share.

Cash & Cash Equivalents 422.83M
Total Debt 54.59M
Net Cash 368.24M
Net Cash Per Share $1.13
Equity (Book Value) 356.97M
Book Value Per Share 1.10
Working Capital 403.11M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$140.94 million and capital expenditures -$716,000, giving a free cash flow of -$141.66 million.

Operating Cash Flow -140.94M
Capital Expenditures -716,000
Depreciation & Amortization 1.14M
Net Borrowing n/a
Free Cash Flow -141.66M
FCF Per Share -$0.43
Full Cash Flow Statement

Margins

Gross Margin 100.00%
Operating Margin -2,997.99%
Pretax Margin -2,844.63%
Profit Margin n/a
EBITDA Margin n/a
EBIT Margin n/a
FCF Margin n/a

Dividends & Yields

TSHA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -26.02%
Shareholder Yield -26.02%
Earnings Yield -11.19%
FCF Yield -11.68%

Analyst Forecast

The average price target for TSHA is $13.00, which is 249.46% higher than the current price. The consensus rating is "Strong Buy".

Price Target $13.00
Price Target Difference 249.46%
Analyst Consensus Strong Buy
Analyst Count 13
Revenue Growth Forecast (3Y) 142.30%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

TSHA has an Altman Z-Score of 9.08 and a Piotroski F-Score of 3.

Altman Z-Score 9.08
Piotroski F-Score 3